Diagnostic accuracy of blood biomarkers and non-invasive scores for the diagnosis of NAFLD and NASH: Systematic review and meta-analysis

Metabolic dysfunction associated fatty liver disease improves detection of high liver stiffness: The rotterdam study

(2021) Laurens van Kleef et al.   HEPATOLOGY

Prevalence and predictors of elevated liver enzyme levels in Mexico: The Mexican National Health and Nutrition Survey, 2016

(2021) Edgar Denova-Gutiérrez et al.   Annals of Hepatology

Advancing the global public health agenda for NAFLD: a consensus statement

(2021) Jeffrey V. Lazarus et al.   Nature Reviews Gastroenterology & Hepatology

Tri-antennary tri-sialylated mono-fucosylated glycan of alpha-1 antitrypsin as a non-invasive biomarker for non-alcoholic steatohepatitis: a novel glycobiomarker for non-alcoholic steatohepatitis

(2020) Koji Ogawa et al.   Scientific Reports

Combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levels

(2020) Kenneth I Zheng et al.   BMJ Open Diabetes Research & Care

Development and validation of a novel non‐invasive test for diagnosing fibrotic non‐alcoholic steatohepatitis in patients with biopsy‐proven non‐alcoholic fatty liver disease

(2020) Feng Gao et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

(2020) Mohammed Eslam et al.   JOURNAL OF HEPATOLOGY

Validation of a Non-Laboratory Based Screening Tool for Predicting Non-Alcoholic Fatty Liver Disease in an Egyptian Setting

(2020) Ekram W. Abd El-Wahab et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Prognostic accuracy of FIB‐4, NAFLD fibrosis score, and APRI for NAFLD‐related events: a systematic review

(2020) Jenny Lee et al.   LIVER INTERNATIONAL

Preferred reporting items for systematic review and meta-analysis of diagnostic test accuracy studies (PRISMA-DTA): explanation, elaboration, and checklist

(2020) Jean-Paul Salameh et al.   BMJ-British Medical Journal

Diagnostic Accuracy of Non-Invasive Fibrosis Models to Detect Change in Fibrosis Stage

(2019) M. Shadab Siddiqui et al.   Clinical Gastroenterology and Hepatology

MACK‐3 (combination of hoMa, Ast and CK18): A promising novel biomarker for fibrotic non‐alcoholic steatohepatitis

(2019) Kee‐Huat Chuah et al.   LIVER INTERNATIONAL

Individualized risk prediction of significant fibrosis in non-alcoholic fatty liver disease using a novel nomogram

(2019) Yu-Jie Zhou et al.   United European Gastroenterology Journal

Evolution of NAFLD and Its Management

(2019) Manpreet S. Mundi et al.   NUTRITION IN CLINICAL PRACTICE

New scoring system combining the FIB-4 index and cytokeratin-18 fragments for predicting steatohepatitis and liver fibrosis in patients with nonalcoholic fatty liver disease

(2018) Toshifumi Tada et al.   BIOMARKERS

The Natural History of Nonalcoholic Fatty Liver Disease—An Evolving View

(2018) Christina C. Lindenmeyer et al.   Clinics in Liver Disease

Prediction of Liver Steatosis Applying a New Score in Subjects from the Brazilian Longitudinal Study of Adult Health

(2018) Hugo Perazzo et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Non-alcoholic fatty liver disease – A global public health perspective

(2018) Zobair M. Younossi   JOURNAL OF HEPATOLOGY

A simpler diagnostic formula for screening nonalcoholic fatty liver disease

(2018) Gong Feng et al.   CLINICAL BIOCHEMISTRY

Development and validation study of a non-alcoholic fatty liver disease risk scoring model among adults in China

(2017) Qian Zhang et al.   FAMILY PRACTICE

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

A model to predict the onset of non-alcoholic fatty liver disease within 2 years in elderly adults

(2017) Ya-Jie Lin et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Application of the combined FibroMeter vibration-controlled transient elastography algorithm in Chinese patients with non-alcoholic fatty liver disease

(2017) Thomson Chi-Wang Loong et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Triglyceride glucose-body mass index is effective in identifying nonalcoholic fatty liver disease in nonobese subjects

(2017) Shujun Zhang et al.   MEDICINE

Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease

(2016) Victor de Lédinghen et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease

(2016) Jérôme Boursier et al.   JOURNAL OF HEPATOLOGY

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016)   JOURNAL OF HEPATOLOGY

Influence of Ethnicity on the Accuracy of Non-Invasive Scores Predicting Non-Alcoholic Fatty Liver Disease

(2016) Ming-Feng Xia et al.   PLoS One

Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study

(2015) J. Cui et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management

(2015) Stuart McPherson et al.   JOURNAL OF HEPATOLOGY

Systematic Review and Meta-Analysis of Studies Evaluating Diagnostic Test Accuracy: A Practical Review for Clinical Researchers-Part I. General Guidance and Tips

(2015) Kyung Won Kim et al.   KOREAN JOURNAL OF RADIOLOGY

ZJU index: a novel model for predicting nonalcoholic fatty liver disease in a Chinese population

(2015) Jinghua Wang et al.   Scientific Reports

Development of non-alcoholic fatty liver disease scoring system among adult medical check-up patients: a large cross-sectional and prospective validation study

(2015) Cosmas Lesmana et al.   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey

(2014) C. E. Ruhl et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Non-invasive score identifies ultrasonography-diagnosed non-alcoholic fatty liver disease and predicts mortality in the USA

(2014) Ching-Lung Cheung et al.   BMC Medicine

OxNASH Score Correlates with Histologic Features and Severity of Nonalcoholic Fatty Liver Disease

(2014) Naim Alkhouri et al.   DIGESTIVE DISEASES AND SCIENCES

A single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)

(2014) Munkhzul Otgonsuren et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Non–Laboratory-Based Self-Assessment Screening Score for Non-Alcoholic Fatty Liver Disease: Development, Validation and Comparison with Other Scores

(2014) Yong-ho Lee et al.   PLoS One

QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies

(2013) Penny F. Whiting   ANNALS OF INTERNAL MEDICINE

External Validation of the Fatty Liver Index for Identifying Nonalcoholic Fatty Liver Disease in a Population-based Study

(2013) Edith M. Koehler et al.   Clinical Gastroenterology and Hepatology

NIKEI: A New Inexpensive and Non-Invasive Scoring System to Exclude Advanced Fibrosis in Patients with NAFLD

(2013) Münevver Demir et al.   PLoS One

Cytokeratin 18, Alanine Aminotransferase, Platelets and Triglycerides Predict the Presence of Nonalcoholic Steatohepatitis

(2013) Wei Cao et al.   PLoS One

Review article: the diagnosis of non-alcoholic fatty liver disease - availability and accuracy of non-invasive methods

(2012) D. Festi et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population

(2012) Yoshio Sumida et al.   BMC GASTROENTEROLOGY

Metabolic markers and ALT cutoff level for diagnosing nonalcoholic fatty liver disease: a community-based cross-sectional study

(2012) Teruki Miyake et al.   JOURNAL OF GASTROENTEROLOGY

Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease

(2011) Leon A Adams et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

(2010) J. K. Dowman et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

(2010) Giovanni Musso et al.   ANNALS OF MEDICINE

Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD)

(2010) Joanna Raszeja-Wyszomirska et al.   BMC GASTROENTEROLOGY

Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease

(2010) S. McPherson et al.   GUT

A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease

(2010) Yoshio Sumida et al.   JOURNAL OF GASTROENTEROLOGY

Diagnosis of different liver fibrosis characteristics by blood tests in non-alcoholic fatty liver disease

(2010) Paul Calès et al.   LIVER INTERNATIONAL

A Biomarker Panel for Non-alcoholic Steatohepatitis (NASH) and NASH-Related Fibrosis

(2010) Zobair M. Younossi et al.   OBESITY SURGERY

Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease

(2009) Jeong-Hoon Lee et al.   DIGESTIVE AND LIVER DISEASE